JP5739882B2 - Ｎ４−（２，２−ジメチル−４−［（二水素ホスホノオキシ）メチル］−３−オキソ−５−ピリド［１，４］オキサジン−６−イル）−５−フルオロ−ｎ２−（３，４，５−トリメトキシフェニル）−２，４−ピリミジンジアミン二ナトリウム塩の合成 - Google Patents

Ｎ４−（２，２−ジメチル−４−［（二水素ホスホノオキシ）メチル］−３−オキソ−５−ピリド［１，４］オキサジン−６−イル）−５−フルオロ−ｎ２−（３，４，５−トリメトキシフェニル）−２，４−ピリミジンジアミン二ナトリウム塩の合成 Download PDF

Info

Publication number
JP5739882B2
JP5739882B2 JP2012518607A JP2012518607A JP5739882B2 JP 5739882 B2 JP5739882 B2 JP 5739882B2 JP 2012518607 A JP2012518607 A JP 2012518607A JP 2012518607 A JP2012518607 A JP 2012518607A JP 5739882 B2 JP5739882 B2 JP 5739882B2
Authority
JP
Japan
Prior art keywords
compound
formula
amide
solvate
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012518607A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532143A5 (enExample
JP2012532143A (ja
Inventor
ウルフレド フェルファー
ウルフレド フェルファー
カール−ハインツ ギセルブレシュト
カール−ハインツ ギセルブレシュト
マイケル ウォルバーグ
マイケル ウォルバーグ
Original Assignee
ライジェル ファーマシューティカルズ， インコーポレイテッド
ライジェル ファーマシューティカルズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライジェル ファーマシューティカルズ， インコーポレイテッド, ライジェル ファーマシューティカルズ， インコーポレイテッド filed Critical ライジェル ファーマシューティカルズ， インコーポレイテッド
Publication of JP2012532143A publication Critical patent/JP2012532143A/ja
Publication of JP2012532143A5 publication Critical patent/JP2012532143A5/ja
Application granted granted Critical
Publication of JP5739882B2 publication Critical patent/JP5739882B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP2012518607A 2009-07-02 2010-07-01 Ｎ４−（２，２−ジメチル−４−［（二水素ホスホノオキシ）メチル］−３−オキソ−５−ピリド［１，４］オキサジン−６−イル）−５−フルオロ−ｎ２−（３，４，５−トリメトキシフェニル）−２，４−ピリミジンジアミン二ナトリウム塩の合成 Active JP5739882B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27007309P 2009-07-02 2009-07-02
US61/270,073 2009-07-02
PCT/US2010/040792 WO2011002999A1 (en) 2009-07-02 2010-07-01 Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt

Publications (3)

Publication Number Publication Date
JP2012532143A JP2012532143A (ja) 2012-12-13
JP2012532143A5 JP2012532143A5 (enExample) 2013-08-15
JP5739882B2 true JP5739882B2 (ja) 2015-06-24

Family

ID=42937685

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012518607A Active JP5739882B2 (ja) 2009-07-02 2010-07-01 Ｎ４−（２，２−ジメチル−４−［（二水素ホスホノオキシ）メチル］−３−オキソ−５−ピリド［１，４］オキサジン−６−イル）−５−フルオロ−ｎ２−（３，４，５−トリメトキシフェニル）−２，４−ピリミジンジアミン二ナトリウム塩の合成

Country Status (21)

Country Link
US (3) US8299242B2 (enExample)
EP (1) EP2448950B1 (enExample)
JP (1) JP5739882B2 (enExample)
CN (1) CN102482305B (enExample)
AU (1) AU2010266213B2 (enExample)
BR (1) BRPI1011888A2 (enExample)
CA (1) CA2766801C (enExample)
CY (1) CY1117489T1 (enExample)
DK (1) DK2448950T3 (enExample)
EA (1) EA021657B1 (enExample)
ES (1) ES2565985T3 (enExample)
HR (1) HRP20160319T1 (enExample)
HU (1) HUE027212T2 (enExample)
ME (1) ME02388B (enExample)
PL (1) PL2448950T3 (enExample)
RS (1) RS54679B1 (enExample)
SG (1) SG176799A1 (enExample)
SI (1) SI2448950T1 (enExample)
SM (1) SMT201600084B (enExample)
UA (1) UA108077C2 (enExample)
WO (1) WO2011002999A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну
US20110206661A1 (en) * 2010-02-24 2011-08-25 Auspex Pharmaceuticals, Inc. Trimethoxyphenyl inhibitors of tyrosine kinase
EP2736487B2 (en) * 2011-07-28 2024-08-28 Rigel Pharmaceuticals, Inc. New (trimethoxyphenylamino)pyrimidinyl formulations
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
MY170437A (en) 2012-06-19 2019-07-31 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
CN102746337B (zh) * 2012-06-21 2014-12-17 成都苑东药业有限公司 一种2，4-嘧啶二胺类化合物及其制备方法
TW201410657A (zh) 2012-08-02 2014-03-16 Endo Pharmaceuticals Inc 經取代胺基－嘧啶衍生物
LT3083648T (lt) * 2013-12-20 2019-01-25 Rigel Pharmaceuticals, Inc. Farmacinis būdas ir tarpiniai junginiai
PL3419628T3 (pl) 2016-02-26 2021-05-31 Debiopharm International Sa Lek do leczenia zakażeń stopy cukrzycowej
EP3509578B1 (en) 2016-09-08 2022-12-21 Glykon Technologies Group, LLC Monomeric bimetal hydroxycitric acid compounds and methods of making and using the same
JP2020536100A (ja) * 2017-10-04 2020-12-10 セルジーン コーポレイション シス−４−［２−｛［（３ｓ，４ｒ）−３−フルオロキサン−４−イル］アミノ｝−８−（２，４，６−トリクロロアニリノ）−９ｈ−プリン−９−イル］−１−メチルシクロヘキサン−１−カルボキサミドの製造プロセス
HRP20230437T1 (hr) 2019-02-14 2023-07-07 Debiopharm International S.A. Formulacija afabicina, postupak izrade iste
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US303022A (en) 1884-08-05 Egg-beater
US324087A (en) 1885-08-11 Abel combs
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US20040024716A1 (en) 2002-04-12 2004-02-05 James Malatesta Mail sorting processes and systems
CN103169708B (zh) 2002-07-29 2018-02-02 里格尔药品股份有限公司 用2,4‑嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法
US7122542B2 (en) 2003-07-30 2006-10-17 Rigel Pharmaceuticals, Inc. Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
US20060047135A1 (en) 2004-08-30 2006-03-02 Chadwick Scott T Process for preparing chloromethyl di-tert-butylphosphate
US7449458B2 (en) * 2005-01-19 2008-11-11 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
US20090114877A1 (en) * 2005-09-13 2009-05-07 Eisai R&D Management Co., Ltd. Composition Containing Stability-Improved Chloromethyl Phosphate Derivatve and Process for Producing Same
US8163902B2 (en) * 2006-11-21 2012-04-24 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну

Also Published As

Publication number Publication date
CN102482305B (zh) 2016-07-13
CA2766801C (en) 2018-03-13
US20110003986A1 (en) 2011-01-06
CN102482305A (zh) 2012-05-30
BRPI1011888A2 (pt) 2016-04-12
US20130274499A1 (en) 2013-10-17
HRP20160319T1 (hr) 2016-04-22
AU2010266213A1 (en) 2012-02-02
SI2448950T1 (sl) 2016-05-31
HUE027212T2 (en) 2016-10-28
RS54679B1 (sr) 2016-08-31
WO2011002999A1 (en) 2011-01-06
EP2448950A1 (en) 2012-05-09
AU2010266213B2 (en) 2015-06-18
CY1117489T1 (el) 2017-04-26
EP2448950B1 (en) 2016-01-13
DK2448950T3 (en) 2016-04-04
US8691798B2 (en) 2014-04-08
SMT201600084B (it) 2016-04-29
EA021657B1 (ru) 2015-08-31
US8481724B2 (en) 2013-07-09
CA2766801A1 (en) 2011-01-06
US8299242B2 (en) 2012-10-30
EA201270114A1 (ru) 2012-05-30
ME02388B (me) 2016-09-20
PL2448950T3 (pl) 2016-06-30
SG176799A1 (en) 2012-01-30
US20130018185A1 (en) 2013-01-17
UA108077C2 (xx) 2015-03-25
HK1169996A1 (zh) 2013-02-15
ES2565985T3 (es) 2016-04-08
JP2012532143A (ja) 2012-12-13

Similar Documents

Publication Publication Date Title
JP5739882B2 (ja) Ｎ４−（２，２−ジメチル−４−［（二水素ホスホノオキシ）メチル］−３−オキソ−５−ピリド［１，４］オキサジン−６−イル）−５−フルオロ−ｎ２−（３，４，５−トリメトキシフェニル）−２，４−ピリミジンジアミン二ナトリウム塩の合成
TWI630201B (zh) 化合物及其調節血紅素之用途
ES2831162T3 (es) Fosfolipidación de imidazoquinolinas y oxoadeninas
US20130165413A1 (en) Process for the preparation of tenofovir
TW201446741A (zh) 化合物及其調節血紅素之用途
JP2017214378A (ja) ホスホン酸エステル誘導体およびその合成方法
ES2539908T3 (es) Métodos de preparación de un compuesto profármaco inhibidor de la fijación del VIH e intermedios
ES2879294T3 (es) Formas polimórficas de Belinostat y procesos para la preparación de las mismas
CN104080785B (zh) 用于制备hiv附着抑制剂哌嗪前药化合物的方法
JP2018501268A (ja) チゾキサニドホスフェート及びアルカンスルホネート並びにその医薬用途
JP5558492B2 (ja) ロスバスタチンまたは医薬として許容されるこの塩の合成のための主要中間体
CN116284140A (zh) 二氟代环状磷酸酯化合物及其制备方法和应用
CA2944805C (en) Phenanthroline phosphonic acid derivative and preparation method therefor and application thereof
ES2989812T3 (es) Proceso para la fabricación de alquilamidotiazoles
CN118845799A (zh) 胞嘧啶类衍生物的医药用途
HK1169996B (en) Synthesis of n4- (2, 2-dimethyl-4- [(dihydrogen phosphonoxy)methyl]-3-oxo-5-pyrido [1, 4]oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl)-2, 4- pyrimidinediamine disodium salt
CA2708148C (en) Reagents and methods for the beta-keto amide synthesis of a synthetic precursor to immunological adjuvant e6020
ES2391784T3 (es) Método para producir difluoruro del ácido tetrafluorotereftálico
TW201943707A (zh) 經取代的二氫茚-4-甲醯胺化合物的製備方法
KR20130018548A (ko) 5-(2,4-다이하이드록시-5-아이소프로필페닐)-엔-에틸-4-(5-메틸-1,2,4-옥사다이아졸-3-일)아이속사졸-3-카복사마이드 화합물의 전구약물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130625

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140716

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140717

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141015

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141022

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150305

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150323

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150330

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150424

R150 Certificate of patent or registration of utility model

Ref document number: 5739882

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250